<SEC-DOCUMENT>0001485003-16-000153-index.html : 20160819
<SEC-HEADER>0001485003-16-000153.hdr.sgml : 20160819
<ACCEPTANCE-DATETIME>20160819161212
ACCESSION NUMBER:		0001485003-16-000153
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20160815
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160819
DATE AS OF CHANGE:		20160819

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Eleven Biotherapeutics, Inc.
		CENTRAL INDEX KEY:			0001485003
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				252025616
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36296
		FILM NUMBER:		161843302

	BUSINESS ADDRESS:	
		STREET 1:		215 FIRST STREET
		STREET 2:		SUITE 400
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		617-871-9911

	MAIL ADDRESS:	
		STREET 1:		215 FIRST STREET
		STREET 2:		SUITE 400
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ebioform8kproformaresultsb.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: ebioform8kproformaresultsb.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>elevenbio-pressreleaseclos.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
Document 2 - file: elevenbio-pressreleaseclos.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>proformafinancials.htm
<DESCRIPTION>EXHIBIT 99.2
<TEXT>
Document 3 - file: proformafinancials.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>ebiologoa09.jpg
<TEXT>
Document 4 - file: ebiologoa09.jpg

</DOCUMENT>
</SEC-DOCUMENT>